Basic Information
ID: ALA4825211
Type: Functional
Description: Antiviral activity against SARS-CoV-2 isolate USA-WA1/2020 infected in Vero E6 cells assessed as reduction in virus induced cytopathic effect
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Strain: USA-WA1/2020
Cell type: Vero E6
Target: SARS-CoV-2(ALA4303835)
Document: ALA4823308
Antiviral activity against SARS-CoV-2 isolate USA-WA1/2020 infected in Vero E6 cells assessed as reduction in virus induced cytopathic effect: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4825211
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 587.97 | 4.66 | 4.66 |
| 519.97 | 3.94 | 3.94 |
| 551.36 | 4.97 | 4.97 |
| 476.92 | 3.40 | 3.40 |
| 518.88 | 3.94 | 3.94 |
| 573.94 | 4.65 | 4.65 |
| 557.87 | 4.18 | 4.18 |